Chemical Exchange Saturation Transfer is Unaffected by Modest Changes in Pressure by Webber, Benjamin Charles et al.
Portland State University 
PDXScholar 
Chemistry Faculty Publications and 
Presentations Chemistry 
4-2012 
Chemical Exchange Saturation Transfer is 
Unaffected by Modest Changes in Pressure 
Benjamin Charles Webber 
Portland State University, benjamin_webber@hotmail.com 
Christiane A. Carney 
Portland State University 
Mark Woods 
Portland State University, mark.woods@pdx.edu 
Follow this and additional works at: https://pdxscholar.library.pdx.edu/chem_fac 
 Part of the Chemistry Commons 
Let us know how access to this document benefits you. 
Citation Details 
Published as: Webber, B.C., Carney, C.E. and Woods, M. (2012), Chemical Exchange Saturation Transfer Is 
Unaffected by Modest Changes in Pressure. Eur. J. Inorg. Chem., 2012: 2040-2043. doi:10.1002/
ejic.201101291 
This Post-Print is brought to you for free and open access. It has been accepted for inclusion in Chemistry Faculty 
Publications and Presentations by an authorized administrator of PDXScholar. For more information, please 
contact pdxscholar@pdx.edu. 
Chemical Exchange Saturation Transfer is Unaffected by Modest
Changes in Pressure
Benjamin C. Webbera, Christiane E. Carneya, and Mark Woodsa,b
Mark Woods: mark.woods@pdx.edu
aDepartment of Chemistry, Portland State University, 1719 SW 10th, Ave, Portland, OR 97201,
USA
bAdvanced Imaging Research Center, Oregon Health and Science, University, Portland OR
97239, USA
Abstract
ParaCEST (paramagnetic Chemical Exchange Saturation Transfer) agents offer an unparalleled
opportunity to perform quantitative molecular imaging by MRI. Agents that can alter the image
contrast they generate in response to changes in local environmental parameters such as pH,
glucose concentration or lactate concentration can be used ratiometrically to quantitatively
describe the local tissue environment. However, when performing such quantitative measurements
it is important that the results are not confounded by changes in a second environmental
parameter. In vivo pressure varies quite considerably, both through the respiratory cycle and from
tissue to tissue (tumors in particular have high interstitial pressures). Since paraCEST agents have
positive activation volumes, their exchange kinetics and therefore the CEST effect that they
generate are necessarily related to pressure. The purpose of this investigation was to examine
whether the relatively small changes in pressure exhibited in vivo could affect CEST sufficiently
to confound attempts to quantify other local environmental parameters. The CEST properties of a
rigid EuDOTA-tetraamide was examined at temperatures ranging from 288 to 319 K, at applied
pressures ranging from 0 to 414 kPa and pre-saturation (B1) powers ranging from 524 to 935 Hz.
At no point was pressure found to affect the CEST generated by this chelate, indicating that
changes in in vivo pressure is unlikely to confound the quantitative measurement of
physiologically relevant parameters by paraCEST MRI.
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Introduction
Exogenous MRI contrast media that generate image contrast through a chemical exchange
saturation transfer (CEST) mechanism have attracted considerable interest over the past
decade or so.[1] One reason for this interest is the potential of such agents to act as reporters
for a variety of important biological markers, such as pH,[2] lactate,[3] glucose,[4] metal ion
concentrations[5] and even gene therapy.[6] Although conventional Gd3+-based MRI contrast
agents have been proposed that report many of these same parameters, CEST agents offer
the advantage that ratiometric methods can be used to quantify the parameter of
interest.[1a, 7] Ratiometric detection by MRI cannot be achieved using responsive Gd3+-
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based agents and more elaborate methods that establish in vivo agent distributions are
required for these agents.[8] Of course if a parameter is to be quantified using a CEST agent
it is imperative that its CEST measurements are not confounded by the presence of or
changes in a second parameter. For instance, both temperature and pH are understood to
intrinsically affect the rate of proton exchange and thus CEST.[2b] As such care must be
taken that any deviation from standard physiological conditions in other parameters (pH,
temperature, etc) do not give rise to erroneous quantification of the parameter of interest,
such as metal ion concentration. For this reason it is important to know how exogenous
CEST agents are affected by all parameters that could influence their CEST response.
Paramagnetic CEST agents or paraCEST agents have provoked considerable interest as
exogenous CEST agents. These agents, commonly derived from Ln3+ DOTA tetraamides
(Chart 1) or structurally related systems, have highly shifted protons that eliminate problems
of direct off-resonance water saturation and permit more rapid exchange rates to be
employed.[1a, 1b] The exchange of water molecules coordinated to the Ln3+ ion in these
chelates occurs through a dissociative (D) mechanism in which the coordinated water
molecule must first dissociate from the chelate before being replaced by a second from the
solvent water. In consequence there is a positive activation volume in the range of 5 – 7
cm3mol−1, associated with the exchange process.[9] Because the volume of the system
changes during exchange the rate of the exchange process will vary depending upon the
pressure it is under; in this case accelerating as the pressure is decreased, decelerating when
the pressure is increased. Since CEST is acutely sensitive to even small changes in exchange
rate it is important to know whether a small change in pressure could generate a change in
CEST. It is well documented that pressure in vivo can vary substantially beyond the obvious
changes in blood pressure during respiration. Conditions such as stroke and cancer for
instance are known to produce significant increases in interstitial pressure. The interstitial
pressure of a tumor varies considerably depending upon the type of tumor and the stage of
development.[10] In vivo pressure is measured relative to the back pressure exerted by the
surrounding tissue and membranes. In these terms the interstitial pressure of a tumour may
vary from marginally above the back pressure to as much as 5.2 kPa above. Indeed
interstitial pressures as high as 2.6 kPa are commonly observed in tumors.[10] If CEST is
sensitive to these small changes in pressure then this must be taken into account when
quantifying a parameter such as pH in a tumor or a stroke when using exogenous CEST
agents. We have accordingly investigated the effect on CEST of modest increases in
pressure that extend well beyond those expected in vivo.
Results and Discussion
In attempting to understand the effect of pressure upon paraCEST it is important to consider
whether an increase in pressure could affect the structure of the agent. Any changes upon the
structure or internal dynamics of a chelate affected by changes pressure would in turn
confound our own measurements. We have recently reported that the Eu3+ DOTA-
tetraamide chelate Eu1 has an extremely rigid structure and does not undergo the
intramolecular exchange processes common to most DOTA-tetraamide chelates.[11] As such
this is an ideal chelate for this study as we can eliminate the possibility that this agent will
alter its structure in response to an increase in pressure and any changes can be attributed
solely to the effect of changing water exchange. Furthermore Eu1 adopts a structure that is
representative of that adopted by most flexible LnDOTA-tetraamide chelates.[11]
Different paraCEST agents exhibit different water exchange kinetics under the same
conditions depending upon the structure and electronics of the ligand system.[12] It is
conceivable that a change in pressure could affect agents with different exchange
characteristics differently. Thus our selected agent may not be representative of the range of
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exchange parameters observed within the paraCEST family. We envisioned that this
problem could be overcome by performing measurements at different temperatures –
affording a range of different exchange kinetics – rather than surveying a range of
paraCEST agents; there are currently insufficient conformationally constrained chelates
available for such a survey.
CEST spectra of a solution of Eu1 in 1:1 CD3CN/H2O (pH 3) were acquired under
atmospheric pressure at 288, 298, 308 and 318 K. The shapes of the resulting CEST spectra
(Figure 1) were consistent with the normally observed effect of temperature,[1a] exhibiting a
sharp CEST peak for the spectra at lower temperatures which gradually broadens, moves
closer to bulk water and reduces in intensity as the temperature increases. Fitting these
spectra to the Bloch equations modified for exchange[13] afforded water exchange kinetics
for Eu1 that are much faster than those previously reported.[11] The water proton residence
lifetime (τM H) at 298 K had been measured at 116 µs in 10% H2O in CD3CN. Not
surprisingly,[14] when the proportion of water in the solvent was increased to 50% (this
work) the exchange rate accelerated considerably affording only a narrow range of τM H
values (Table 1). pH can also be used to modulate proton exchange rates, in this case even
though the sample pH is comparatively low it lies within a pH range expected to afford the
slowest exchange kinetics and these would not be expected to change on raising the value as
high as pH 8.[15] Such relatively rapid exchange occurring even at comparatively low
temperatures frustrated our plan to span a wide range of exchange kinetics by varying
temperature. The final range of atmospheric pressure water proton residence lifetimes
achieved was a relatively small increase from 60 µs at 288 K to 20 µs at 318 K (Table 1).
The pressure of each sample in the NMR tube was then increased from atmospheric pressure
to 139, 276 and eventually 414 kPa. CEST spectra were then acquired at each temperature
and pressure. In each case no change in the magnitude or shape of the CEST peak
corresponding to bound water was observed (Figure 2).
In Figures 1 & 2 the data shown was acquired using a pre-saturation (B1) power of 935 Hz.
However, it has been shown that the magnitude of the CEST effect obtained with a given B1
power varies substantially as the water exchange kinetics vary.[1a] To eliminate the
possibility that a change in B1 power increases the susceptibility of CEST to changes in
pressure the magnitude of CEST from the coordinated water was measured as a function of
B1 power from 524 Hz to 935 Hz. CEST itself is inherently sensitive to changes in the B1
power[13] and so there is a considerable increase in CEST as the B1 power increases. But no
difference in is observed in the amount of CEST generated for a given B1 power as the
applied pressure is increased from 0 to 414 kPa (Figure 3).
Conclusions
A good guide to the minimum change in contrast-to-noise (CNR) required for detection
comes from fMRI experiments and is generally thought to be about a 3% change in water
signal intensity. The physiologically relevant range of pressures probably only extends as far
as a high systolic pressure plus the maximum likely interstitial pressure of a tumor; probably
about 32 kPa. Within this pressure range any variation in the CEST generated from Eu1
under the conditions examined herein lies within experimental error and is certainly much
smaller than the 3% change needed to be observed during an MR acquisition. It is important
to note however, that Eu1 represents a fairly narrow range of possible exchange kinetics and
that these observations may not hold true for systems with radically different water
exchange kinetics. Nonetheless, we can conclude that pressure is unlikely to be a
confounding parameter for the quantification of biologically relevant parameters by
paraCEST MRI.
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The preparation of Eu1 has been described previously.[11] All CEST spectra were acquired
on a Bruker Avance IIa operating at 400.13 MHz and equipped with a 5mm broadband
probe and temperature control. The chelate Eu1 was dissolved in a 1:1: mixture of CD3CN
and H2O at a concentration of 17.1 mM. The sample was placed in a heavy walled 5 mm
NMR tube quipped with a Young valve (Wilmad). CEST spectra were acquired using a pre-
saturation power of 935 Hz and a pre-saturation time of 10 s at 288, 298, 308 and 318 K.
Pressure was then applied to the sample using an over pressure of helium and the tube
sealed. CEST data were then acquired at the same four temperatures. In each case the
temperature of the sample was adjusted prior to pressurization to eliminate errors in sample
pressure arising from changes in sample temperature. The effect of changing pre-saturation
power was determined by applying pre-saturation pulses (of 10 s duration) at a fixed offset
to the sample and varying B1 from 935 to 524 Hz.
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CEST spectra of Eu1 in 1:1 CD3CN/H2O acquired at different temperatures.
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The maximal CEST effect of Eu1 at 288 K (58 ppm), 298 K (55 ppm), 308 K (52 ppm) and
318 K (49 ppm) in 1:1 CD3CN/H2O as a function of pressure. Solid lines are linear fits to
the data.
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The magnitude of the CEST effect of Eu1 in 1:1 CD3CN/H2O at 288 K (diamonds) and 318
K (circles) with 0 kPa (open symbols) and 414 kPa (closed symbols) as a function of the
pre-saturation power, B1.
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The structures of LnDOTA-tetraamides and Eu1
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Table 1
The atmospheric pressure water proton residence lifetimes (τMH) of Eu1 in 1:1 CD3CN/H2O as a function of
temperature.
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